Janux Therapeutics' Chief Business Officer buys and sells shares.

Janux Therapeutics, Inc. (JANX) recently disclosed that Meyer Andrew Hollman, the company's Chief Business Officer, engaged in a series of transactions involving the purchase and sale of shares. Specifically, Hollman acquired 3333 shares at a price of $10.59 per share on December 1, 2025. Subsequently, he sold 2700 shares at $32.85 per share on the same day, and also sold 633 shares at $33.52 per share on December 1, 2025. These transactions reflect Hollman's interest in the company and his efforts to manage the company's stock holdings.